Human skin processing affects clinical outcome in allograft recipients

Area of Science:

• * Transplantation Science
• * Regenerative Medicine
• * Burn Care

Background:

• * Skin allografts are vital for treating burn patients, but contamination during procurement remains a significant challenge.
• * Current validation procedures for skin allografts lack standardization.
• * The impact of tissue viability on allograft outcomes is not well understood.

Purpose of the Study:

• * To identify donor and procurement variables linked to bacterial contamination and tissue viability in skin allografts.
• * To evaluate the influence of skin characteristics and procurement factors on clinical outcomes in allograft recipients.
• * To determine the association between tissue viability and post-transplantation outcomes.

Main Methods:

• * Retrospective analysis of 2120 skin samples from 610 donors to assess contamination and viability factors.
• * Evaluation of two patient series (155 and 195 recipients) to correlate skin characteristics and procurement variables with clinical outcomes.
• * Statistical analysis to identify significant associations between various parameters and graft outcomes.

Main Results:

• * Post-processing contamination was significantly associated with donor type, cause of death, hospitalization length, procurement site, surgeon, procurement-to-banking interval, and decontamination method.
• * Tissue viability showed a negative association with freezing.
• * Donor age correlated with recipient hospitalization length; procalcitonin and PCR values correlated with the decontamination method.
• * No significant link was found between tissue viability and clinical outcomes (hospitalization length, donor cause of death, inflammatory markers).

Conclusions:

• * Donor and procurement variables significantly impact skin allograft quality and recipient outcomes.
• * The decontamination method is a critical factor in skin allograft processing and requires standardization.
• * Further research into optimizing procurement and processing protocols is essential for improving allograft success rates.